BBVA USA Bancshares’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,473
| Closed | -$270K | – | 503 |
|
|
2019
Q2 | $270K | Sell |
1,473
-639
| -30% | -$117K | 0.02% | 468 |
|
|
2019
Q1 | $388K | Sell |
2,112
-535
| -20% | -$98.3K | 0.02% | 398 |
|
|
2018
Q4 | $439K | Sell |
2,647
-295
| -10% | -$48.9K | 0.03% | 355 |
|
|
2018
Q3 | $567K | Buy |
2,942
+483
| +20% | +$93.1K | 0.03% | 367 |
|
|
2018
Q2 | $418K | Sell |
2,459
-83
| -3% | -$14.1K | 0.03% | 396 |
|
|
2018
Q1 | $414K | Sell |
2,542
-171
| -6% | -$27.9K | 0.03% | 399 |
|
|
2017
Q4 | $407K | Sell |
2,713
-517
| -16% | -$77.6K | 0.03% | 400 |
|
|
2017
Q3 | $491K | Sell |
3,230
-633
| -16% | -$96.2K | 0.03% | 367 |
|
|
2017
Q2 | $498K | Buy |
3,863
+385
| +11% | +$49.6K | 0.03% | 363 |
|
|
2017
Q1 | $380K | Sell |
3,478
-726
| -17% | -$79.3K | 0.03% | 408 |
|
|
2016
Q4 | $310K | Sell |
4,204
-430
| -9% | -$31.7K | 0.02% | 452 |
|
|
2016
Q3 | $404K | Sell |
4,634
-344
| -7% | -$30K | 0.03% | 393 |
|
|
2016
Q2 | $428K | Sell |
4,978
-613
| -11% | -$52.7K | 0.03% | 365 |
|
|
2016
Q1 | $444K | Buy |
5,591
+341
| +6% | +$27.1K | 0.03% | 369 |
|
|
2015
Q4 | $660K | Buy |
5,250
+866
| +20% | +$109K | 0.05% | 300 |
|
|
2015
Q3 | $457K | Buy |
4,384
+977
| +29% | +$102K | 0.04% | 332 |
|
|
2015
Q2 | $420K | Buy |
3,407
+622
| +22% | +$76.7K | 0.02% | 381 |
|
|
2015
Q1 | $328K | Buy |
2,785
+1,060
| +61% | +$125K | 0.01% | 463 |
|
|
2014
Q4 | $205K | Buy |
+1,725
| New | +$205K | 0.01% | 531 |
|